← Back to headlines
Wedbush Bullish on Black Diamond Therapeutics (BDTX) After Silevertinib Program Progress
Wedbush maintains a bullish outlook on Black Diamond Therapeutics (BDTX) following advancements in its Silevertinib program.
25 Mar, 19:31 — 25 Mar, 19:31
Sources
Showing 1 of 1 sources
Related Stories
Japan Household Spending Falls for Eighth Consecutive Month Amid Rising Prices
15m ago
South Korea Prepares Military Deployment Near Strait of Hormuz Amid Regional Tensions
24m ago
US Probes Fatal Strike on Iranian Wedding Linked to American Munitions
28m ago
Skepticism Mounts Over Reported $100 Billion US-Venezuela Oil Deal
43m ago